111 Cash on Hand 2018-2025 | YI

111 cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
111 Annual Cash on Hand
(Millions of US $)
2024 $71
2023 $95
2022 $134
2021 $148
2020 $248
2019 $100
2018 $161
2017 $70
111 Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $77
2024-12-31 $71
2024-09-30 $88
2024-06-30 $85
2024-03-31 $87
2023-12-31 $95
2023-09-30 $120
2023-06-30 $101
2023-03-31 $128
2022-12-31 $134
2022-09-30 $122
2022-06-30 $132
2022-03-31 $142
2021-12-31 $148
2021-09-30 $168
2021-06-30 $187
2021-03-31 $178
2020-12-31 $248
2020-09-30 $179
2020-06-30 $105
2020-03-31 $74
2019-12-31 $100
2019-09-30 $110
2019-06-30 $144
2019-03-31 $155
2018-09-30 $180
2017-12-31 $70
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.065B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.159B 58.73
Doximity (DOCS) United States $11.724B 54.28
Hims & Hers Health (HIMS) United States $11.606B 120.58
Tempus AI (TEM) United States $10.382B 0.00
IRhythm Technologies (IRTC) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $3.760B 58.76
Hinge Health (HNGE) United States $3.663B 0.00
Privia Health (PRVA) United States $2.509B 171.50
Enovis (ENOV) United States $1.745B 9.73
Phreesia (PHR) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.559B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
10x Genomics (TXG) United States $1.523B 0.00
Azenta (AZTA) United States $1.469B 68.25
Evolent Health (EVH) United States $1.343B 114.40
Omnicell (OMCL) United States $1.301B 22.96
Claritev (CTEV) United States $0.725B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Veradigm (MDRX) United States $0.499B 0.00
Standard BioTools (LAB) United States $0.471B 0.00
Butterfly Network (BFLY) United States $0.443B 0.00
Talkspace (TALK) United States $0.416B 124.25
TruBridge (TBRG) United States $0.326B 722.33
Outset Medical (OM) United States $0.321B 0.00
Nyxoah SA (NYXH) Belgium $0.271B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.221B 0.00
Zepp Health (ZEPP) Netherlands $0.188B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
American Well (AMWL) United States $0.129B 0.00
EUDA Health Holdings (EUDA) Singapore $0.121B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.102B 3.87
ImmunoPrecise Antibodies (IPA) Canada $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00